Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: Comparison with cytomorphologic, cytogenetic, and molecular genetic findings-Reference-Cited by-同舟云学术

Stability of leukemia-associated aberrant immunophenotypes in patients with acute myeloid leukemia between diagnosis and relapse: Comparison with cytomorphologic, cytogenetic, and molecular genetic findings

Published:2004 Issue:1 Volume:62B Page:25-38
ISSN:0196-4763
Container-title:Cytometry
language:en
Short-container-title:Cytometry

Author:

Voskova Daniela,Schoch Claudia,Schnittger Susanne,Hiddemann Wolfgang,Haferlach Torsten,Kern Wolfgang

Publisher

Wiley

Subject

Cell Biology,Endocrinology,Hematology,Biophysics,Pathology and Forensic Medicine

Reference70 articles.

1. Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 Trial

2. ACUTE MYELOID LEUKEMIA: TREATMENT OVER 60

3. Recent advances in the treatment of acute leukemia: 1999

4. Molecular evolution of acute myeloid leukaemia in relapse: unstable N-ras and FLT3 genes compared with p53 gene

5. Detection of minimal residual disease in acute leukemia: methodologic advances and clinical significance [see comments]

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Minimal Residual Disease in Acute Myeloid Leukemia: Old and New Concepts;International Journal of Molecular Sciences;2024-02-10

2. Monitoring Measurable/Minimal Residual Disease in Acute Myeloid Leukemia: Multiparametric Flow Cytometry-Based Approach;Indian Journal of Medical and Paediatric Oncology;2023-11-27

3. Challenges facing minimal residual disease testing for acute myeloid leukemia and promising strategies to overcome them;Expert Review of Hematology;2023-11-21

4. Prognostic value of combined WT1 and multiparameter flow cytometry assessment for measurable residual disease after induction in non-APL acute myeloid leukemia;Scandinavian Journal of Clinical and Laboratory Investigation;2023-06-24

5. Challenges of detecting measurable/minimal disease in acute leukemia;Seminars in Diagnostic Pathology;2023-05